Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ouwens Mario JNM"'
Publikováno v:
BMC Medical Research Methodology, Vol 12, Iss 1, p 9 (2012)
Abstract Background The results of Randomized Controlled Trials (RCTs) on time-to-event outcomes that are usually reported are median time to events and Cox Hazard Ratio. These do not constitute the sufficient statistics required for meta-analysis or
Externí odkaz:
https://doaj.org/article/32cab9cbd3b248efb7c020a4e5a85613
Publikováno v:
Open Access Medical Statistics.
Mario JNM Ouwens,1 Stefan GAJ Driessen,1 Suntje Sander-Struckmeier2 1Biometrics, Abbott Healthcare Products B.V., Weesp, The Netherlands; 2Gastroenterology/Hepatology, Abbott Laboratories, Hannover, Germany Background: S-adenosylmethionine (AdoMet) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dovemedicalp::32efc02f8101be3512d9143598ef7f5f
https://www.dovepress.com/preferred-s-adenosylmethionine-prescription-in-routine-practice-for-in-peer-reviewed-article-OAMS
https://www.dovepress.com/preferred-s-adenosylmethionine-prescription-in-routine-practice-for-in-peer-reviewed-article-OAMS
Publikováno v:
Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy; Jun2016, Vol. 9, p201-205, 5p
Autor:
Qiao Q; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., Ouwens MJ; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., Grandy S; Global Medicines Development, AstraZeneca, Gaithersburg, MD, USA., Johnsson K; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., Kostev K; Epidemiology and Evidence-Based Medicine, Real-World Evidence Solutions, IMS Health, Frankfurt am Main, Germany.
Publikováno v:
Diabetes, metabolic syndrome and obesity : targets and therapy [Diabetes Metab Syndr Obes] 2016 Jun 28; Vol. 9, pp. 201-5. Date of Electronic Publication: 2016 Jun 28 (Print Publication: 2016).